Skip to content

Clinical trials

Phase 1 Ovarian Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Country / region: Switzerland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20111
20121
20132
20141
20162
20171
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Array Biopharma, now a wholly owned subsidiary of Pfizer1
Cristiana Sessa1
Dr Jean Yannis PERENTES1
EMD Serono1
GlaxoSmithKline1
PharmaMar1
Seagen, a wholly owned subsidiary of Pfizer1
Swiss Cancer Institute1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms12
Carcinoma, Non-Small-Cell Lung5
Breast Neoplasms4
Esophageal Neoplasms3
Colorectal Neoplasms2
Melanoma2
Small Cell Lung Carcinoma2
Squamous Cell Carcinoma of Head and Neck2
Stomach Neoplasms2
Endometrial Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.